Dixon Hubard Feinour & Brown Inc Buys Dollar General Corp, Verizon Communications Inc, Vanguard FTSE Emerging Markets, Sells WellCare Health Plans Inc, Supernus Pharmaceuticals Inc, Invesco QQQ Trust Series 1

Investment company Dixon Hubard Feinour & Brown Inc buys Dollar General Corp, Verizon Communications Inc, Vanguard FTSE Emerging Markets, Medpace Holdings Inc, Atlassian Corporation PLC, Vanguard Total Stock Market, Intel Corp, CyberArk Software, Horizon Therapeutics PLC, Ingersoll-Rand PLC, iShares MSCI China ETF, Dover Corp, MercadoLibre Inc, Colgate-Palmolive Co, Nike Inc, Globant SA, Lockheed Martin Corp, Schlumberger, Willis Towers Watson PLC, Diageo PLC, Annaly Capital Management Inc, Telefonaktiebolaget L M Ericsson, sells WellCare Health Plans Inc, Supernus Pharmaceuticals Inc, Invesco QQQ Trust Series 1, SAP SE, BP PLC, Vale SA, iShares Core S&P Small-Cap, iShares S&P 100 during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Dixon Hubard Feinour & Brown Inc. As of 2019Q1, Dixon Hubard Feinour & Brown Inc owns 176 stocks with a total value of $332 million. These are the details of the buys and sells.

For the details of DIXON HUBARD FEINOUR & BROWN INC's stock buys and sells, go to https://www.gurufocus.com/guru/dixon+hubard+feinour+%26+brown+inc/current-portfolio/portfolio

These are the top 5 holdings of DIXON HUBARD FEINOUR & BROWN INC
  1. Apple Inc (AAPL) - 68,608 shares, 3.93% of the total portfolio. Shares added by 4.02%
  2. Microsoft Corp (MSFT) - 104,716 shares, 3.72% of the total portfolio. Shares added by 1.61%
  3. PayPal Holdings Inc (PYPL) - 99,626 shares, 3.12% of the total portfolio. Shares added by 2.27%
  4. Stryker Corp (SYK) - 47,962 shares, 2.86% of the total portfolio. Shares reduced by 5.02%
  5. Thermo Fisher Scientific Inc (TMO) - 34,221 shares, 2.82% of the total portfolio. Shares added by 0.52%
New Purchase: Dollar General Corp (DG)

Dixon Hubard Feinour & Brown Inc initiated holding in Dollar General Corp. The purchase prices were between $107.71 and $120.68, with an estimated average price of $116.19. The stock is now traded at around $120.47. The impact to a portfolio due to this purchase was 2.35%. The holding were 65,386 shares as of .

New Purchase: Medpace Holdings Inc (MEDP)

Dixon Hubard Feinour & Brown Inc initiated holding in Medpace Holdings Inc. The purchase prices were between $49.38 and $70.58, with an estimated average price of $59.82. The stock is now traded at around $55.81. The impact to a portfolio due to this purchase was 1.22%. The holding were 68,685 shares as of .

New Purchase: Atlassian Corporation PLC (TEAM)

Dixon Hubard Feinour & Brown Inc initiated holding in Atlassian Corporation PLC. The purchase prices were between $84.48 and $115.5, with an estimated average price of $101.84. The stock is now traded at around $129.13. The impact to a portfolio due to this purchase was 0.34%. The holding were 10,075 shares as of .

New Purchase: Vanguard Total Stock Market (VTI)

Dixon Hubard Feinour & Brown Inc initiated holding in Vanguard Total Stock Market. The purchase prices were between $124.77 and $146.62, with an estimated average price of $139.34. The stock is now traded at around $147.06. The impact to a portfolio due to this purchase was 0.32%. The holding were 7,317 shares as of .

New Purchase: CyberArk Software Ltd (CYBR)

Dixon Hubard Feinour & Brown Inc initiated holding in CyberArk Software Ltd. The purchase prices were between $69.42 and $119.05, with an estimated average price of $95.08. The stock is now traded at around $129.00. The impact to a portfolio due to this purchase was 0.16%. The holding were 4,475 shares as of .

New Purchase: Horizon Therapeutics PLC (HPR)

Dixon Hubard Feinour & Brown Inc initiated holding in Horizon Therapeutics PLC. The purchase prices were between $16.5 and $25.2, with an estimated average price of $20.53. The stock is now traded at around $23.60. The impact to a portfolio due to this purchase was 0.13%. The holding were 16,600 shares as of .

Added: Verizon Communications Inc (VZ)

Dixon Hubard Feinour & Brown Inc added to a holding in Verizon Communications Inc by 162.25%. The purchase prices were between $53.28 and $60.88, with an estimated average price of $56.61. The stock is now traded at around $58.40. The impact to a portfolio due to this purchase was 1.63%. The holding were 147,783 shares as of .

Added: Vanguard FTSE Emerging Markets (VWO)

Dixon Hubard Feinour & Brown Inc added to a holding in Vanguard FTSE Emerging Markets by 236.97%. The purchase prices were between $37.67 and $43.15, with an estimated average price of $41.12. The stock is now traded at around $40.27. The impact to a portfolio due to this purchase was 1.58%. The holding were 174,697 shares as of .

Added: Intel Corp (INTC)

Dixon Hubard Feinour & Brown Inc added to a holding in Intel Corp by 31.01%. The purchase prices were between $44.49 and $54.64, with an estimated average price of $50.66. The stock is now traded at around $45.18. The impact to a portfolio due to this purchase was 0.25%. The holding were 64,549 shares as of .

Added: Ingersoll-Rand PLC (IR)

Dixon Hubard Feinour & Brown Inc added to a holding in Ingersoll-Rand PLC by 73.74%. The purchase prices were between $90.03 and $107.95, with an estimated average price of $101.14. The stock is now traded at around $121.55. The impact to a portfolio due to this purchase was 0.08%. The holding were 5,690 shares as of .

Added: Telefonaktiebolaget L M Ericsson (ERIC)

Dixon Hubard Feinour & Brown Inc added to a holding in Telefonaktiebolaget L M Ericsson by 20.02%. The purchase prices were between $8.29 and $9.82, with an estimated average price of $9.03. The stock is now traded at around $9.40. The impact to a portfolio due to this purchase was 0.02%. The holding were 51,740 shares as of .

Sold Out: WellCare Health Plans Inc (WCG)

Dixon Hubard Feinour & Brown Inc sold out a holding in WellCare Health Plans Inc. The sale prices were between $230.61 and $282.5, with an estimated average price of $258.4.

Sold Out: Supernus Pharmaceuticals Inc (SUPN)

Dixon Hubard Feinour & Brown Inc sold out a holding in Supernus Pharmaceuticals Inc. The sale prices were between $32.77 and $41.99, with an estimated average price of $37.19.

Sold Out: Invesco QQQ Trust Series 1 (QQQ)

Dixon Hubard Feinour & Brown Inc sold out a holding in Invesco QQQ Trust Series 1. The sale prices were between $149.82 and $182.57, with an estimated average price of $169.41.

Sold Out: SAP SE (SAP)

Dixon Hubard Feinour & Brown Inc sold out a holding in SAP SE. The sale prices were between $95.46 and $115.46, with an estimated average price of $106.3.

Sold Out: Vale SA (VALE)

Dixon Hubard Feinour & Brown Inc sold out a holding in Vale SA. The sale prices were between $11.17 and $14.86, with an estimated average price of $12.96.



Here is the complete portfolio of DIXON HUBARD FEINOUR & BROWN INC. Also check out:

1. DIXON HUBARD FEINOUR & BROWN INC's Undervalued Stocks
2. DIXON HUBARD FEINOUR & BROWN INC's Top Growth Companies, and
3. DIXON HUBARD FEINOUR & BROWN INC's High Yield stocks
4. Stocks that DIXON HUBARD FEINOUR & BROWN INC keeps buying